Methods of genomic evaluation in livestock

US10323280B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10323280-B2
Application numberUS-201615294179-A
CountryUS
Kind codeB2
Filing dateOct 14, 2016
Priority dateOct 16, 2015
Publication dateJun 18, 2019
Grant dateJun 18, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention encompasses methods for increasing genetic progress in livestock, and for genetic dissemination, including the use of amniocentesis to obtain fetal amniocytes for use in genomic evaluation and cloning.

First claim

Opening claim text (preview).

What we claim is: 1. A method of determining a genomic estimated breeding value (GEBV) or a genomic predicted transmitting ability (GPTA) of a non-human mammalian fetus comprising: extracting DNA from one or more fetal amniocytes; genotyping the DNA to obtain a genotype for the fetus; and determining a GEBV or a GPTA of the fetus based on the genotype. 2. The method of claim 1 , further comprising the step of isolating the one or more fetal amniocytes from amniotic fluid. 3. The method of claim 1 , further comprising the step of cloning the fetus using a fetal amniocyte. 4. The method of claim 1 , wherein the one or more fetal amniocytes comprise amniotic fluid-derived mesenchymal stem cells. 5. The method of claim 1 , wherein the genotype is an SNP genotype. 6. The method of claim 5 , wherein the DNA is genotyped using a SNP chip or array. 7. The method of claim 1 , further comprising the step of calculating a selection index using the GEBV or the GPTA. 8. The method of claim 1 , further comprising the step of calculating a selection index using the GEBV or the GPTA. 9. The method of claim 1 , further comprising the step of verifying parentage of the fetus using the genotype. 10. The method of claim 1 , wherein the non-human mammalian fetus is a bovid. 11. A method of increasing genetic progress in a population of non-human mammals comprising: extracting DNA from one or more amniocytes derived from a fetus from the population; genotyping the DNA to obtain a genotype for the fetus; selecting the fetus as a parent for the population based on the genotype; and cloning the fetus to produce a clone. 12. The method of claim 11 , wherein the step of cloning the fetus comprises using an amniocyte derived from the fetus. 13. The method of claim 11 , wherein the one or more amniocytes comprise amniotic fluid-derived mesenchymal stem cells. 14. The method of claim 11 , further comprising the step of determining a GEBV or a GPTA of the fetus based on the genotype. 15. The method of claim 14 , wherein the genotype is an SNP genotype. 16. The method of claim 11 , further comprising the steps of fertilizing an oocyte from the clone with sperm from a male in the population to produce an embryo; and transferring the embryo into a female recipient for gestation. 17. The method of claim 11 , wherein the sperm is sex-sorted sperm of which at least 60% bear an X-chromosome. 18. A method of genetic dissemination comprising: extracting DNA from one or more amniocytes derived from a fetus; genotyping the DNA to obtain a genotype for the fetus; and selecting the fetus as a donor of oocytes for use in IVF based on the genotype. 19. The method of claim 18 , further comprising the steps of collecting one or more oocytes from the donor; and fertilizing the one or more oocytes with sex-sorted sperm to produce one or more female embryos. 20. The method of claim 19 , further comprising the step of transferring the one or more female embryos into one or more recipient females. 21. The method of claim 20 , wherein the one or more recipient females comprise production animals. 22. The method of claim 20 , further comprising the steps of producing one or more heifers or cows from the one or more female embryos; and producing milk from the one or more heifers or cows. 23. The method of claim 18 , further comprising the step of determining a GEBV or a GPTA of the fetus based on the genotype. 24. The method of claim 23 , wherein the genotype is an SNP genotype.

Assignees

Inventors

Classifications

  • C12Q1/6876Primary

    Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title

  • Bovine · CPC title

  • Animal zootechnically ameliorated · CPC title

  • Animal traits, i.e. production traits, including athletic performance or the like · CPC title

  • Polymorphic or mutational markers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10323280B2 cover?
The invention encompasses methods for increasing genetic progress in livestock, and for genetic dissemination, including the use of amniocentesis to obtain fetal amniocytes for use in genomic evaluation and cloning.
Who is the assignee on this patent?
Inguran Llc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6876. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).